Cold Sore Treatment Market Scope
A cold sore, also called herpes labialis, is a viral infection caused by the herpes simplex virus. It is characterized by red, fluid-filled blisters or ulcers that appear on the lips and around the mouth. These blisters often appear as spots when they break a crust that forms over the resulting wound. According to statistics released by WebMD LLC, an estimated 40% of the US adult population get recurrent cold sores. The high demand for novel treatment methods and enormous investments in research and development are drivers for market growth. In 2019, the Abreva brand, one of the leading cold sore brands in the United States, accounted for approximately 71.1 percent of total US dollar sales.
The market study is being classified by Type (Non-Pharmacological Treatment and Pharmacological Treatment), by Application (Hospitals, Homecare, Specialty Clinics and Others) and major geographies with country level break-up.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Cold Sore Treatment market throughout the predicted period.
Squarex (United States), Merix Pharmaceutical Corp (United States), AiCuris (Germany), GlaxoSmithKline plc (United Kingdom), Medivir AB (Sweden), Renaissance Pharma, Inc. (United States), Deerfield (United States), Otsuka Holdings Co. Ltd. (Japan), Mylan N.V. (United States), Teva Pharmaceutical Industries Ltd. (Israel), Cipla Inc. (India), Alembic Pharmaceuticals Limited (India), Zydus Cadila (India), Amneal Pharmaceuticals LLC (United States), Sun Pharmaceutical Industries Ltd. (India) and Hetero Drugs (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Novartis AG (Switzerland) and Tolmar Pharmaceuticals, Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global Cold Sore Treatment market by Type, Application and Region.
On the basis of geography, the market of Cold Sore Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In August 2019, Merix Pharmaceutical Corp launched RELEEV, which contains VIRACEA, a proprietary herbal extract formulation made from Echinacea extract and antiseptic benzalkonium chloride for the treatment of cold sores. This drug claims to relieve cold sore pain in just 3 to 10 minutes and relieve other symptoms in 24 hours. The introduction of this drug offers a novel topical treatment and important advances that will allow a complete cure for this condition.
- Huge Financial Support to the Researchers for Developing Novel Intervention
- High Demand for Disease-Specific Novel Treatment
- Increase in Modes of Transmission of the Infectious Disease
- Lack of Cleanliness in Developing Regions
- Growing Prevalence of Cold Sore Worldwide
- A Rise in Prevalence of HSV Infection
- Increase in Rate of New Infections
- Continuous Mutations in the Microorganisms Leading To New Strains
- A Rapid Pace in the Near Future Due To Rising Adoption of Online Purchases in Developed Countries
- Advancement in Treatment and Incorporation of Novel Formulation Can Improve the Ease the Pain of Cold Sores
- Patent Expiry of Branded Drugs and Introduction of Generics
- Low Healthcare Budget in Some Developing Countries
Key Target AudienceProviders of Cold Sore BodiesTreatment, End-Users, Potential Investors, Market Research Firms, Regulatory and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase